Moran, A., Ramakrishnan, S., Borg, C., Connolly, C., Couillard, S., Mwasuku, C., . . . Lehtimaki, L. (2020). Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma. European Respiratory Society.
Dyfyniad Arddull ChicagoMoran, A., S. Ramakrishnan, C. Borg, C. Connolly, S. Couillard, C. Mwasuku, I. Pavord, T. Hinks, and L. Lehtimaki. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
Dyfyniad MLAMoran, A., et al. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.